Zobrazeno 1 - 5
of 5
pro vyhledávání: '"59"'
Autor:
Mohammad Shehab, Fatema Alrashed, Ahmad Alfadhli, Khazna Alotaibi, Abdullah Alsahli, Hussain Mohammad, Preethi Cherian, Irina Al-Khairi, Thangavel Alphonse Thanaraj, Arshad Channanath, Hamad Ali, Mohamed Abu-Farha, Jehad Abubaker, Fahd Al-Mulla
Publikováno v:
Vaccines
Vaccines; Volume 9; Issue 12; Pages: 1471
Vaccines, Vol 9, Iss 1471, p 1471 (2021)
Vaccines; Volume 9; Issue 12; Pages: 1471
Vaccines, Vol 9, Iss 1471, p 1471 (2021)
Introduction: The immunogenicity of SARS-CoV-2 vaccines in patients with inflammatory bowel disease (IBD) on biologic therapies is not well studied. The goal of this study was to measure the serological response to BNT162b2 and ChAdOx1 nCoV-19 vaccin
Autor:
Alexander T. Gallo, Lisa Scanlon, Jade Clifford, Lawson Patten-Williams, Lachlan Tweedie, Dani Li, Sandra M. Salter
Publikováno v:
Vaccines; Volume 10; Issue 12; Pages: 2041
Background: Four COVID-19 vaccines are approved for use in Australia: Pfizer-BioNTech BNT162b2 (Comirnaty), AstraZeneca ChAdOx1 (Vaxzevria), Moderna mRNA-1273 (Spikevax), and Novavax NVX-CoV2373 (Nuvaxovid). We sought to examine the type and manageme
Autor:
Merav Heshin-Bekenstein, Amit Ziv, Natasa Toplak, Siman Lazauskas, Danielle Kadishevich, Efrat Ben-Nun Yaari, Adi Miller-Barmak, Yonatan Butbul Aviel, Esther Saiag, Sara Pel, Ori Elkayam, Yosef Uziel, Victoria Furer
Publikováno v:
Vaccines; Volume 11; Issue 4; Pages: 819
Background: To explore the long-term safety and dynamics of the immune response induced by the second and third doses of the BNT162b2 mRNA COVID-19 vaccine in adolescents with juvenile-onset autoimmune inflammatory rheumatic diseases (AIIRDs) compare
Autor:
Giovanni Corrao, Matteo Franchi, Danilo Cereda, Francesco Bortolan, Olivia Leoni, Catia Rosanna Borriello, Petra Giulia Della Valle, Marcello Tirani, Giovanni Pavesi, Antonio Barone, Michele Ercolanoni, Jose Jara, Massimo Galli, Guido Bertolaso
Publikováno v:
Vaccines; Volume 10; Issue 6; Pages: 845
We aimed to identify individual features associated with increased risk of post-vaccine SARS-CoV-2 infection and severe COVID-19 illness. We performed a nested case–control study based on 5,350,295 citizens from Lombardy, Italy, aged ≥ 12 years w
Autor:
Luz Cabral, Ezequiel Forte, Manuel Alfonso Baños González, Juan Martín Busso, John Jairo Araujo, Ricardo Lopez Santi, Piero Custodio–Sanchez, Roberto Flores, Leonardo Josué Ramírez Zambrano, Máxima Mendez Castillo, Alvaro Sosa Liprandi, Ezequiel J. Zaidel, Carmen Roa, Juan Erriest, Jorge Camilletti, Mirecly Guzman Ramos, Adrian Baranchuk, Gustavo Solache Ortiz, Bernardo Spitz
Publikováno v:
Vaccines, Vol 9, Iss 123, p 123 (2021)
Vaccines
Volume 9
Issue 2
Vaccines
Volume 9
Issue 2
Background: Influenza vaccination (IV) and Pneumococcus vaccination (PV) are recommended for patients with cardiometabolic diseases. This study aimed to evaluate the immunization rate of ambulatory cardiometabolic patients during the COVID-19 pandemi